ONM-501

OncoNano Caps $68.4M Series B Round With $18.4M Equity Investment From CPRIT for Cancer-Fighting Tech and Therapies

by | Oct 25, 2021
The Cancer Prevention and Research Institute of Texas (CPRIT) will convert previous grant awards to an equity investment. OncoNano uses pH as a biomarker to detect metastatic cancer. The technology "lights up" a tumor in imaging during real-time surgery.
MORE